Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation

Jorn Brouwer*, Vincent J. Nijenhuis, Ronak Delewi, Renicus S. Hermanides, Wouter Holvoet, Christophe L. F. Dubois, Peter Frambach, Bernard De Bruyne, Gert K. van Houwelingen, Jan A. S. Van der Heyden, Petr Tousek, Frank van der Kley, Ian Buysschaert, Carl E. Schotborgh, Bert Ferdinande, Pim van der Harst, John Roosen, Joyce Peper, Frederick W. F. Thielen, Leo VeenstraDean R. P. P. Chan Pin Yin, Martin J. Swaans, Benno J. W. M. Rensing, Arnoud W. J. van 't Hof, Leo Timmers, Johannes C. Kelder, Pieter R. Stella, Jan Baan, Jurrien M. ten Berg

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1447-1457
Number of pages11
JournalNew England Journal of Medicine
Volume383
Issue number15
DOIs
Publication statusPublished - 8 Oct 2020

Keywords

  • DUAL ANTIPLATELET THERAPY
  • REPLACEMENT
  • RISK
  • DEFINITIONS
  • TAVI
  • METAANALYSIS
  • OUTCOMES
  • DISEASE
  • ESC

Cite this